BioMarin Pharmaceutical Inc. (BMRN)

BioMarin Pharmaceutical Revenue

BioMarin Pharmaceutical had revenue of $2.47B in the twelve months ending March 31, 2024, with 13.74% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $648.83M with 8.79% year-over-year growth. In the year 2023, BioMarin Pharmaceutical had annual revenue of $2.42B with 15.42% growth.

• Revenue (ttm): $2.47B
• Revenue Growth: +13.74%
• P/S Ratio: 6.21
• Revenue / Employee: $726,740
• Employees: 3,401
• Market Cap: 15.35B USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	2.42B	323.19M	15.42%
Dec 31, 2022	2.10B	249.76M	13.53%
Dec 31, 2021	1.85B	-14.18M	-0.76%
Dec 31, 2020	1.86B	156.41M	9.18%
Dec 31, 2019	1.70B	212.84M	14.27%
Dec 31, 2018	1.49B	177.57M	13.52%
Dec 31, 2017	1.31B	196.79M	17.62%
Dec 31, 2016	1.12B	226.96M	25.50%
Dec 31, 2015	889.90M	140.61M	18.77%
Dec 31, 2014	749.28M	200.80M	36.61%
Dec 31, 2013	548.49M	47.76M	9.54%
Dec 31, 2012	500.72M	59.37M	13.45%
Dec 31, 2011	441.36M	65.09M	17.30%
Dec 31, 2010	376.27M	51.61M	15.90%
Dec 31, 2009	324.66M	28.16M	9.50%
Dec 31, 2008	296.49M	174.91M	143.86%
Dec 31, 2007	121.58M	37.37M	44.38%
Dec 31, 2006	84.21M	58.54M	228.06%
Dec 31, 2005	25.67M	7.03M	37.70%
Dec 31, 2004	18.64M	6.54M	54.06%
Dec 31, 2003	12.10M	-	-
Dec 31, 2002	0	-	-
Dec 31, 2001	0	-	-
Dec 31, 2000	9.71M	4.41M	83.28%
Dec 31, 1999	5.30M	4.11M	345.38%
Dec 31, 1998	1.19M	-873.92K	-42.34%
Dec 31, 1997	2.06M	733.28K	55.11%
Dec 31, 1996	1.33M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.